Literature DB >> 9794802

Lutropins appear to contact two independent sites in the extracellular domain of their receptors.

M P Bernard1, R V Myers, W R Moyle.   

Abstract

Human chorionic gonadotropin (hCG) and bovine lutropin (bLH), a hormone chemically more similar to most mammalian lutropins than hCG, interact with the extracellular domains of their gonadal lutropin receptors (LHRs). These portions of the rat and human LHRs are 85% identical and both receptors bind hCG with high, albeit not identical, affinity. However, at least 1000-fold more bLH is required to inhibit binding of radiolabelled hCG to the human LHR than to the rat LHR, a phenomenon that proved useful for identifying regions of the extracellular domain that contact lutropins. Previous studies using truncated receptors and lutropin/follitropin receptor chimaeras localized most, if not all, high-affinity ligand contacts to the N-terminal three-fifths of the rat LHR extracellular domain. We report here that 10-fold more bLH was needed to inhibit binding of labelled hCG to rat/human LHR chimaeras containing the N-terminal three-fifths of the human LHR extracellular domain than to the rat LHR. Unexpectedly, 100-fold more bLH was required to inhibit binding of labelled hCG to chimaeras containing the C-terminal one-fifth of the human LHR extracellular domain than to the rat LHR. The ability of the C-terminal portion of the human LHR extracellular domain to inhibit bLH binding suggests this region of the receptor also contacts the ligand even though it is not needed for ligand binding. The extracellular domains of all the glycoprotein hormone receptors are thought to be horseshoe-shaped, a consequence of their leucine-rich repeat motifs. Portions of the ligand that become located within the cavity created by the concave surface of the horseshoe would have the opportunity to contact residues in the C-terminal portion of the extracellular domain. Changes to the ligand or receptor that influence this interaction would be expected to alter binding and confound efforts to identify residues in key ligand-receptor contacts.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9794802      PMCID: PMC1219823          DOI: 10.1042/bj3350611

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  32 in total

1.  Influence of subunit interactions on lutropin specificity. Implications for studies of glycoprotein hormone function.

Authors:  L Cosowsky; W Lin; Y Han; M P Bernard; R K Campbell; W R Moyle
Journal:  J Biol Chem       Date:  1997-02-07       Impact factor: 5.157

2.  Lutropin-choriogonadotropin receptor: an unusual member of the G protein-coupled receptor family.

Authors:  K C McFarland; R Sprengel; H S Phillips; M Köhler; N Rosemblit; K Nikolics; D L Segaloff; P H Seeburg
Journal:  Science       Date:  1989-08-04       Impact factor: 47.728

3.  Characterization of the primate luteinizing hormone receptor in testis homogenates and Leydig cells.

Authors:  T F Davies; P C Walsh; G D Hodgen; M L Dufau; K J Catt
Journal:  J Clin Endocrinol Metab       Date:  1979-04       Impact factor: 5.958

4.  Crystal structure at 1.7 A resolution of VEGF in complex with domain 2 of the Flt-1 receptor.

Authors:  C Wiesmann; G Fuh; H W Christinger; C Eigenbrot; J A Wells; A M de Vos
Journal:  Cell       Date:  1997-11-28       Impact factor: 41.582

5.  Human growth hormone and extracellular domain of its receptor: crystal structure of the complex.

Authors:  A M de Vos; M Ultsch; A A Kossiakoff
Journal:  Science       Date:  1992-01-17       Impact factor: 47.728

6.  Conversion of human choriogonadotropin into a follitropin by protein engineering.

Authors:  R K Campbell; D M Dean-Emig; W R Moyle
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

7.  Crystal structure of porcine ribonuclease inhibitor, a protein with leucine-rich repeats.

Authors:  B Kobe; J Deisenhofer
Journal:  Nature       Date:  1993 Dec 23-30       Impact factor: 49.962

8.  Co-evolution of ligand-receptor pairs.

Authors:  W R Moyle; R K Campbell; R V Myers; M P Bernard; Y Han; X Wang
Journal:  Nature       Date:  1994-03-17       Impact factor: 49.962

9.  Thyrotropin-luteinizing hormone/chorionic gonadotropin receptor extracellular domain chimeras as probes for thyrotropin receptor function.

Authors:  Y Nagayama; H L Wadsworth; G D Chazenbalk; D Russo; P Seto; B Rapoport
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

10.  Amino-terminal leucine-rich repeats in gonadotropin receptors determine hormone selectivity.

Authors:  T Braun; P R Schofield; R Sprengel
Journal:  EMBO J       Date:  1991-07       Impact factor: 11.598

View more
  3 in total

Review 1.  Models of glycoprotein hormone receptor interaction.

Authors:  William R Moyle; Win Lin; Rebecca V Myers; Donghui Cao; John E Kerrigan; Michael P Bernard
Journal:  Endocrine       Date:  2005-04       Impact factor: 3.633

2.  Follitropin receptors contain cryptic ligand binding sites.

Authors:  Win Lin; Michael P Bernard; Donghui Cao; Rebecca V Myers; John E Kerrigan; William R Moyle
Journal:  Mol Cell Endocrinol       Date:  2006-10-23       Impact factor: 4.102

3.  Defining structural and functional dimensions of the extracellular thyrotropin receptor region.

Authors:  Gunnar Kleinau; Sandra Mueller; Holger Jaeschke; Paul Grzesik; Susanne Neumann; Anne Diehl; Ralf Paschke; Gerd Krause
Journal:  J Biol Chem       Date:  2011-04-27       Impact factor: 5.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.